Loading...
0
New

Fetal Bovine Serum Market by Application (Biopharmaceuticals, Cell Culture, Human & Animal Vaccine Production, and Others) and End User (Biotechnology & Pharmaceutical Company, Academic Institute, and Research Laboratory): Global Opportunity Analysis and Industry Forecast, 2018–2025

LI_195261
Pages: 219
May 2019 | 1202 Views
 
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 87
Charts: 30
 

Fetal Bovine Serum Market Outlook - 2025

The global fetal bovine serum market was valued at $695 million in 2017 and is estimated to reach at $1,037 million by 2025, registering a CAGR of 5.1 % from 2018 to 2025.Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin, and clotting factors, it contains high amount of nutritional and macromolecular factors essential for cell growth. Bovine serum albumin is the major component of FBS. Growth factors in FBS are essential for the maintenance and growth of cultured cells. FBS also contains a variety of small molecules like amino acids, sugars, lipids, and hormones. Fetal bovine serum (FBS) finds its application in several biotechnological research purposes, including cancer research, development of biopharmaceuticals, human & animal vaccines, and other research purposes. In addition, FBS is used as an additional media supplement for cell culture, owing to the presence of high content of embryonic growth-promoting factors. It is considered as the most effective growth promoter as compared to the other animal sera available for most cell culture systems. In addition, the significantly lower content of antibodies compared to adult and newborn sera minimizes the risk of antibody cross-reaction with cells in culture. The quality of FBS is determined primarily at the blood collection site and the raw serum processing center. Appropriate collection is fundamental in maintaining the natural growth-promoting properties of fetal blood, thus achieving consistent and superior performance of the final FBS products.

Fetal Bovine Serum Market

Get more information on this report : Request Sample Pages

Rise in R&D activities toward the introduction of novel biopharmaceuticals has considerably fueled the growth of the global fetal bovine serum market. In addition, expansion of biopharmaceutical industry is anticipated to fuel the global fetal bovine serum market growth. Moreover, increase in investments and funding for research interventions in both developed and developing countries drives the market growth. However, ethical & scientific concerns associated with the potential misuse of biotechnology research practices and dearth of skilled personnel restrict the fetal bovine serum market. In addition, ease of availability of alternatives such as chemically defined media, serum-free media, and others hampers the market growth. In addition, the fetal bovine serum market is experiencing paradigm shift, due to significant rise in prices of FBS over the recent years, which acts as a key restraint. This increase in price is attributed to the significant surge in demand for FBS while decrease in its production. On the contrary, untapped potential of emerging markets are anticipated to provide lucrative opportunities in the near future to the key players operating in the fetal bovine serum market.

Fetal Bovine Serum Market by Application

Get more information on this report : Request Sample Pages

Application segment review

Based on application, the fetal bovine serum market is classified into biopharmaceuticals, cell culture, human & animal vaccine production, and others. The cell culture segment was the largest contributor to the fetal bovine serum market, owing to the fact that it is most widely used as a supplement during the cell culture protocols. Fetal bovine serum is widely used as an additional supplement in the media to provide optimum growth factors to the cultured cells. The biopharmaceuticals segment is anticipated to grow at the fastest rate during the forecast period. This is attributed to the significant increase in biotech R&D activities toward the introduction of novel biopharmaceuticals for the treatment of various diseases across the globe. Moreover, demand continues to rise for biopharmaceutical production using mammalian cell culture supplemented with fetal bovine serum.

Fetal Bovine Serum Market by End User

Get more information on this report : Request Sample Pages

End User segment review

Based on end user, the fetal bovine serum industry is bifurcated into biotechnology & pharmaceutical company, academic institute and research laboratory. Biotechnology & pharmaceutical company segment accounted for the highest revenue in 2017 and in anticipated to grow at the fastest growth rate during the forecast period. This is attributed to the increased R&D and production of vaccines as well as biopharmaceuticals in these companies.

Fetal Bovine Serum Market by Region

Get more information on this report : Request Sample Pages

Region segment review

Region wise, the fetal bovine sera market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2018, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increased funding by government agencies and rise in focus to develop biopharmaceuticals in this region. However, as per fetal bovine serum market forecast, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025. This is attributed to rise in investment by the government as well as private companies for research activities. In addition, increase in penetrance of key players including Thermo Fisher, Hi- Media and others in this region further fuels the fetal bovine serum market.

The report provides a comprehensive analysis of the leading companies operating in the global fetal bovine serum market such as GE Healthcare, Merck KGaA (Sigma Aldrich), HiMedia Laboratories Pvt., Ltd., Bio-Techne, Biowest, Biological Industries, Atlas Biologicals, Rocky Mountain Biologicals, PAN-Biotech, and Thermo Fisher Scientific Inc. The other players in the value chain (not included in the report) include Takara Bio, Inc., Tissue Culture Biologicals, Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH and Nucleus Biologics.

Key Benefits for Fetal Bovine Serum Market:

  • The study provides an in-depth analysis of the global fetal bovine serum market share with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the global fetal bovine serum market size is provided.
  • A comprehensive quantitative fetal bovine serum market analysis is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
  • An extensive analysis of the key segments of the industry helps to understand the global fetal bovine serum market trends.
  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Fetal Bovine Serum Key Market Segments:

By Application

  • Biopharmaceuticals
  • Cell Culture
  • Human & Animal Vaccine Production
  • Others

By End User

  • Biotechnology & Pharmaceutical Companies
  • Academic Institute
  • Research Laboratory

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Saudi Arabia
    • South Africa
    • Brazil
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Primary research
1.4.2.    Secondary research
1.4.3.    Analyst tools and models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study
2.2.    Key findings

2.2.1.    Top impacting factors
2.2.2.    Top investment pockets

2.3.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Parent/Peer Market Overview
3.3.    Key Forces Shaping Fetal Bovine Serum Industry/Market

3.3.1.    Moderate bargaining power of suppliers
3.3.2.    Low bargaining power of buyers
3.3.3.    Low threat of substitutes
3.3.4.    Low intensity of rivalry
3.3.5.    Moderate Threat of Substitution

3.4.    Pricing Analysis

3.4.1.    Pricing Analysis of Fetal Bovine Serum, By Region, 2018 & 2025

3.5.    Market evolution/Industry roadmap
3.6.    Value Chain Analysis
3.7.    Impact of government regulations on global fetal bovine serum market
3.8.    Industry Pain point analysis
3.9.    Case Studies

3.9.1.    Case Study 01

3.10.    Market dynamics

3.10.1.    Drivers

3.10.1.1.    Rise in R&D Investment
3.10.1.2.    High demand for fetal bovine sera
3.10.1.3.    Surge in biopharmaceutical production

3.10.2.    Restraints

3.10.2.1.    High price
3.10.2.2.    Increased use of alternatives

3.10.3.    Opportunity

3.10.3.1.    Untapped potential of the emerging economies

CHAPTER 4:    FETAL BOVINE SERUM MARKET, BY APPLICATION

4.1.    Overview
4.2.    Biopharmaceuticals

4.2.1.    Key market trends, growth factors and opportunities
4.2.2.    Market size and forecast, by region
4.2.3.    Market analysis by country

4.3.    Cell Culture

4.3.1.    Key market trends, growth factors, and opportunities
4.3.2.    Market size and forecast, by region
4.3.3.    Market analysis by country

4.4.    Human and Animal Vaccine Production

4.4.1.    Key market trends, growth factors, and opportunities
4.4.2.    Market size and forecast, by region
4.4.3.    Market analysis by country

4.5.    Others

4.5.1.    Key market trends, growth factors, and opportunities
4.5.2.    Market size and forecast, by region
4.5.3.    Market analysis by country

CHAPTER 5:    FETAL BOVINE SERUM MARKET, BY END USER

5.1.    Overview
5.2.    Biotechnology & Pharmaceutical Company

5.2.1.    Market size and forecast, by region
5.2.2.    Market analysis by country

5.3.    Academic Institute

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis by country

5.4.    Research Laboratory

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis by country

CHAPTER 6:    FETAL BOVINE SERUM MARKET, BY REGION

6.1.    Overview
6.2.    North America

6.2.1.    Key market trends and opportunities
6.2.2.    Market size and forecast, by application
6.2.3.    Market size and forecast, by end user
6.2.4.    Market analysis by country

6.2.4.1.    U.S. Market size and forecast, by application
6.2.4.2.    Market size and forecast, by end user

6.2.4.3.    Canada
6.2.4.4.    Canada Market size and forecast, by application
6.2.4.5.    Canada Market size and forecast, by end user
6.2.4.6.    Mexico Market size and forecast, by application
6.2.4.7.    Mexico Market size and forecast, by end user

6.3.    Europe

6.3.1.    Key market trends, growth factors and opportunities
6.3.2.    Market size and forecast, by application
6.3.3.    Europe Market size and forecast, by end user
6.3.4.    Europe Market size and forecast, by country

6.3.4.1.    UK Market size and forecast, by application
6.3.4.2.    UK Market size and forecast, by end user
6.3.4.3.    Germany Market size and forecast, by application
6.3.4.4.    Germany Market size and forecast, by end user
6.3.4.5.    France Market size and forecast, by application
6.3.4.6.    France Market size and forecast, by end user
6.3.4.7.    Italy Market size and forecast, by application
6.3.4.8.    Market size and forecast, by end user
6.3.4.9.    Spain Market size and forecast, by application
6.3.4.10.    Spain Market size and forecast, by end user
6.3.4.11.    Rest of Europe Market size and forecast, by application
6.3.4.12.    Rest of Europe Market size and forecast, by end user

6.4.    Asia-Pacific

6.4.1.    Key market trends, growth factors and opportunities
6.4.2.    Market size and forecast, by application
6.4.3.    Market size and forecast, by end user
6.4.4.    Market size and forecast, by country

6.4.4.1.    China Market size and forecast, by application
6.4.4.2.    China Market size and forecast, by end user
6.4.4.3.    India Market size and forecast, by application
6.4.4.4.    India Market size and forecast, by end user
6.4.4.5.    Japan Market size and forecast, by application
6.4.4.6.    Japan Market size and forecast, by end user
6.4.4.7.    South Korea Market size and forecast, by application
6.4.4.8.    South Korea Market size and forecast, by end user
6.4.4.9.    Australia Market size and forecast, by application
6.4.4.10.    Australia Market size and forecast, by end user
6.4.4.11.    Rest of Asia-Pacific Market size and forecast, by application
6.4.4.12.    Rest of Asia-Pacific Market size and forecast, by end user

6.5.    LAMEA

6.5.1.    Key market trends, growth factors and opportunities
6.5.2.    Market size and forecast, by application
6.5.3.    Market size and forecast, by end user
6.5.4.    Market size and forecast, by country

6.5.4.1.    Brazil Market size and forecast, by application
6.5.4.2.    Brazil Market size and forecast, by end user
6.5.4.3.    Saudi Arabia Market size and forecast, by application
6.5.4.4.    Saudi Arabia Market size and forecast, by end user
6.5.4.5.    Saudi Arabia Market size and forecast, by application
6.5.4.6.    Saudi Arabia Market size and forecast, by end user
6.5.4.7.    Rest of LAMEA Market size and forecast, by application
6.5.4.8.    Rest of LAMEA Market size and forecast, by end user

CHAPTER 7:    COMPETITIVE LANDSCAPE

7.1.    Introduction

7.1.1.    MARKET PLAYER POSITIONING, 2018

7.2.    Market share analysis of top players, 2018 (%)
7.3.    Top winning strategies
7.4.    Competitive dashboard
7.5.    Competitive heatmap

CHAPTER 8:    COMPANY PROFILES: FETAL BOVINE SERUM MARKET

8.1.    ATLAS BIOLOGICALS

8.1.1.    Company overview
8.1.2.    Company snapshot
8.1.3.    Operating business segments
8.1.4.    Product portfolio

8.2.    BIO-TECHNE (ATLANTA BIOLOGICS)

8.2.1.    Company overview
8.2.2.    Company snapshot
8.2.3.    Operating business segments
8.2.4.    Product portfolio
8.2.5.    Business performance
8.2.6.    Key strategic moves and developments

8.3.    BIOLOGICAL INDUSTRIES

8.3.1.    Company overview
8.3.2.    Company snapshot
8.3.3.    Operating business segments
8.3.4.    Product portfolio

8.4.    GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

8.4.1.    Company overview
8.4.2.    Company snapshot
8.4.3.    Operating business segments
8.4.4.    Product portfolio
8.4.5.    Business performance

8.5.    HIMEDIA LABORATORIES PVT., LTD

8.5.1.    Company overview
8.5.2.    Company snapshot
8.5.3.    Operating business segments
8.5.4.    Product portfolio

8.6.    Merck KGAA (SIGMA ALDRICH)

8.6.1.    Company overview
8.6.2.    Company snapshot
8.6.3.    Operating business segments
8.6.4.    Product portfolio
8.6.5.    Business performance
8.6.6.    Key strategic moves and developments

8.7.    PAN-BIOTECH

8.7.1.    Company overview
8.7.2.    Company snapshot
8.7.3.    Operating business segments
8.7.4.    Product portfolio

8.8.    ROCKY MOUNTAIN BIOLOGICALS (RMBIO)

8.8.1.    Company overview
8.8.2.    Company snapshot
8.8.3.    Operating business segments
8.8.4.    Product portfolio

8.9.    SERA SCANDIA A/S (BIOWEST)

8.9.1.    Company overview
8.9.2.    Company snapshot
8.9.3.    Operating business segments
8.9.4.    Product portfolio

8.10.    THERMO FISHER SCIENTIFIC INC.

8.10.1.    Company overview
8.10.2.    Company snapshot
8.10.3.    Operating business segments
8.10.4.    Product Portfolio
8.10.5.    Business performance

8.11.    Other Key Player Profile

8.11.1.    Key player snapshot

LIST OF TABLES

TABLE 01.    GLOBAL FETAL BOVINE SERUM MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 02.    FETAL BOVINE SERUM MARKET REVENUE FOR BIOPHARMACEUTICALS, BY REGION 2017–2025 ($MILLION)
TABLE 03.    FETAL BOVINE SERUM MARKET REVENUE FOR CELL CULTURE, BY REGION 2017–2025($MILLION)
TABLE 04.    FETAL BOVINE SERUM MARKET REVENUE FOR HUMAN AND ANIMAL VACCINE PRODUCTION, BY REGION 2017–2025($MILLION)
TABLE 05.    FETAL BOVINE SERUM MARKET REVENUE FOR OTHERS, BY REGION 2017–2025($MILLION)
TABLE 06.    FETAL BOVINE SERUM MARKET REVENUE FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANY, BY REGION 2017–2025($MILLION)
TABLE 07.    FETAL BOVINE SERUM MARKET REVENUE FOR ACADEMIC INSTITUTE, BY REGION 2017–2025($MILLION)
TABLE 08.    FETAL BOVINE SERUM MARKET REVENUE FOR RESEARCH LABORATORY, BY REGION 2017-2025($MILLION)
TABLE 09.    NORTH AMERICA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 10.    NORTH AMERICA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 11.    NORTH AMERICA FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2017–2025($MILLION)
TABLE 12.    U.S. FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 13.    U.S. FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 14.    CANADA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 15.    CANADA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 16.    MEXICO FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 17.    MEXICO FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 18.    EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 19.    EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 20.    EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2017–2025($MILLION)
TABLE 21.    UK FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 22.    UK FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 23.    GERMANY FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 24.    GERMANY FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 25.    FRANCE FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 26.    FRANCE FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 27.    ITALY FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 28.    ITALY FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 29.    SPAIN FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 30.    SPAIN FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 31.    REST OF EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 32.    REST OF EUROPE FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 33.    ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 34.    ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 35.    ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2017–2025($MILLION)
TABLE 36.    CHINA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 37.    CHINA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 38.    INDIA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 39.    INDIA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 40.    JAPAN FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 41.    JAPAN FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 42.    SOUTH KOREA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 43.    SOUTH KOREA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 44.    AUSTRALIA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 45.    AUSTRALIA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 46.    REST OF ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 47.    REST OF ASIA-PACIFIC FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 48.    LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 49.    LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 50.    LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY COUNTRY 2017–2025($MILLION)
TABLE 51.    BRAZIL FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 52.    BRAZIL FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 53.    SAUDI ARABIA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 54.    SAUDI ARABIA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 55.    SOUTH AFRICA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 56.    AFRICA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 57.    REST OF LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY APPLICATION 2017–2025($MILLION)
TABLE 58.    REST OF LAMEA FETAL BOVINE SERUM MARKET REVENUE, BY END USER 2017–2025($MILLION)
TABLE 59.    COMPETITIVE DASHBOARD
TABLE 60.    ATLAS: COMPANY SNAPSHOT
TABLE 61.    ATLAS: PRODUCT PORTFOLIO
TABLE 62.    BIO-TECHNE COMPANY SNAPSHOT
TABLE 63.    BIO-TECHNE OPERATING SEGMENTS
TABLE 64.    BIO-TECHNE: PRODUCT PORTFOLIO
TABLE 65.    BI: COMPANY SNAPSHOT
TABLE 66.    BIOLOGICAL INDUSTRIES PRODUCT PORTFOLIO
TABLE 67.    GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 68.    GE HEALTHCARE: OPERATING SEGMENTS
TABLE 69.    GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 70.    HIMEDIA: COMPANY SNAPSHOT
TABLE 71.    HIMEDIA: OPERATING SEGMENTS
TABLE 72.    GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 73.    MERCK: COMPANY SNAPSHOT
TABLE 74.    MERCK: OPERATING SEGMENTS
TABLE 75.    MERCK: PRODUCT PORTFOLIO
TABLE 76.    PAN: COMPANY SNAPSHOT
TABLE 77.    PAN: PRODUCT PORTFOLIO
TABLE 78.    RMBIO: COMPANY SNAPSHOT
TABLE 79.    RMBIO: PRODUCT PORTFOLIO
TABLE 80.    SERA SCANDIA: COMPANY SNAPSHOT
TABLE 81.    BIOWEST: OPERATING SEGMENTS
TABLE 82.    SERA SCANDIA: PRODUCT PORTFOLIO
TABLE 83.    THERMO FISHER: COMPANY SNAPSHOT
TABLE 84.    THERMO FISHER: OPERATING SEGMENTS
TABLE 85.    THERMO FISHER: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 01.    KEY MARKET SEGMENTS
FIGURE 02.    EXECUTIVE SUMMARY
FIGURE 03.    TOP IMPACTING FACTORS
FIGURE 04.    TOP INVESTMENT POCKETS
FIGURE 05.    MARKET EVOLUTION/INDUSTRY ROADMAP
FIGURE 06.    VALUE CHAIN ANALYSIS
FIGURE 07.    GLOBAL FETAL BOVINE SERUM MARKET, BY APPLICATION, 2017-2025
FIGURE 08.    COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET REVENUE FOR BIOPHARMACEUTICALS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09.    COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR CELL CULTURE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10.    COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR HUMAN AND ANIMAL VACCINE PRODUCTION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11.    COMPARATIVE SHARE ANALYSIS OF OTHER MARKET, BY COUNTRY, 2027 & 2025 (%)
FIGURE 12.    GLOBAL FETAL BOVINE SERUM MARKET, BY END USER, 2017-2025
FIGURE 13.    COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14.    COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR ACADEMIC INSTITUTE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15.    COMPARATIVE SHARE ANALYSIS OF FETAL BOVINE SERUM MARKET FOR RESEARCH LABORATORY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16.    MARKET PLAYER POSITIONING, 2018
FIGURE 17.    MARKET SHARE ANALYSIS: FETAL BOVINE SERUM MARKET, 2018 (%)
FIGURE 18.    COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 19.    BIO-TECHNE NET SALES, 2015–2017 ($MILLION)
FIGURE 20.    BIO-TECHNE REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21.    BIO-TECHNE REVENUE SHARE, BY REGION 2017 (%)
FIGURE 22.    GE HEALTHCARE: NET SALES, 2016–2018 ($MILLION)
FIGURE 23.    GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24.    GE HEALTHCARE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25.    MERCK: REVENUE, 2016–2018 ($MILLION)
FIGURE 26.    MERCK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27.    MERCK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28.    THERMO FISHER: NET SALES, 2016–2018 ($MILLION)
FIGURE 29.    THERMO FISHER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30.    THERMO FISHER: REVENUE SHARE BY REGION, 2018 (%)

 
 

Biotechnology research has witnessed an exponential growth in recent years and is anticipated to create tremendous opportunities in the near future as well. Fetal bovine serum plays a crucial role in biotechnology research. The growth of the fetal bovine serum market is driven by factors such as increase in funding & investment for R&D activities and innovation in biopharmaceutical products. In addition, significant rise in the use of sera for cell culture and low supply of the same are anticipated to increase the cost in the near future. However, scientific and ethical concerns associated with fetal bovine sera and high cost are anticipated to hamper the growth of the market.

North America accounted for a major share in the fetal bovine serum market, owing to the fact that the government agencies in this region have increased their focus toward biotechnological research. In addition, presence of leading biotech companies and rise in biotechnology R&D activities boost the market growth in this region. Furthermore, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period, due to rise in presence of small-scale biotech companies and increased government initiatives toward promoting biotechnology research in this region.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Fetal Bovine Serum Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Fetal Bovine Serum Market"
Purchase Enquiry